Description:

Pharmacotherapy for ARDS has been tested in preclinical and clinical studies. However, to date, no pharmacologic interventions have proven effective. Personalized medicine targeting the different ARDS phenotypes has emerged as an option to improve survival.

Learning Objectives:

•ARDS pathophysiology and the main pharmacologic agents that may counteract certain pathophysiologic features will be discussed. Furthermore, the importance of personalized medicine in improving the therapeutic approach to ARDS will be addressed.